Global /United Kingdom /Healthcare /Biotechnology /T9G
chevron_leftBack
Vidac Pharma Holding Plc logo

Vidac Pharma Holding Plc

T9G
• XETRA: T9G • Delayed
0.5700EUR -5.9%
0.6583 USD
As of 11 June 2026, Vidac Pharma Holding Plc has a market cap of $36.13M USD, ranking #32916 globally and #745 in the United Kingdom. It ranks #2971 in the Healthcare sector, and #573 in the Biotechnology industry.
Global Rank
32916
Country Rank
745
Sector Rank
2971
Industry Rank
573
Key Stats
Market Cap
$36.13MUSD
31.28M EUR
Company Profile
Country (HQ)
United Kingdom
Sector
Healthcare
Industry
Biotechnology
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-5.9% -1.7% -8.1% -24% 9K% 9K%

News

Loading...

Markets

Exchange Ticker Price
Deutsche Börse Xetra
MIC: XETR
PRIMARY
T9G
ISIN: GB00BM9XQ619
Shares Out.:
51.625M1
TV:
XETR: T9G
SA:
ETR: T9G
YF:
T9G.DE
GF:
FRA: T9G
BA:
T9G
MS:
XETR: T9G
0.5700 EUR
Frankfurt Stock Exchange
MIC: XFRA
T9G
ISIN: GB00BM9XQ619
TV:
FWB: T9G
SA:
FRA: T9G
YF:
T9G.F
GF:
FRA: T9G
BA:
T9G
MS:
XFRA: T9G
0.5820 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

Similar Companies

Industry: Biotechnology (United Kingdom)
Name
Market Cap diff.
PE
Verona Pharma plc
VRNA
$9.22B
25K%
-
Immunocore Holdings plc
IMCR
$1.42B
4K%
-
COMPASS Pathways plc
CMPS
$1.13B
3K%
-
Oxford Biomedica plc
OXB
$972.19M
726.61M GBP
3K%
-
Silence Therapeutics plc
SLNCF
$265.93M
636%
-
Diaceutics PLC
DXRX
$195.38M
146.03M GBP
441%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
Amgen Inc.
AMGN
$182.42B
505K%
23.9
Gilead Sciences, Inc.
GILD
$159.92B
443K%
19.0
argenx SE
ARGX
$47.8B
41.39B EUR
132K%
39.9
Samsung Biologics Co.,Ltd.
207940
$44.82B
68.19T KRW
124K%
35.5
CSL Ltd.
CSL
$42.25B
60.27B AUD
117K%
29.3
Lonza Group AG
LONN
$42.17B
33.71B CHF
117K%
37.2
chevron_leftBack